Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage I Prostate Adenocarcinoma”

262 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 262 results

Not applicableLooking for participantsNCT06325046
What this trial is testing

Adaptive Radiation Therapy (ART) Stereotactic Ablative Body Radiotherapy (SABR) for Primary Localized Prostate Cancer

Who this might be right for
Localized Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8+1 more
Mayo Clinic 144
Testing effectiveness (Phase 2)Study completedNCT00589472
What this trial is testing

Androgen Deprivation Therapy and Vorinostat Followed by Radical Prostatectomy in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate CancerStage IIA Prostate Cancer+2 more
National Cancer Institute (NCI) 19
Early research (Phase 1)Study completedNCT00003439
What this trial is testing

Interleukin-12 in Treating Patients With Refractory Advanced-Stage Ovarian Cancer or Abdominal Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 36
Early research (Phase 1)Study completedNCT00005627
What this trial is testing

Estramustine, Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT00078923
What this trial is testing

Soy Isoflavones in Treating Patients Who Are Undergoing Radical Prostatectomy for Stage I or Stage II Adenocarcinoma of the Prostate

Who this might be right for
Prostate Cancer
Barbara Ann Karmanos Cancer Institute 32
Large-scale testing (Phase 3)Study completedNCT03070886
What this trial is testing

Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery

Who this might be right for
Stage I Prostate Adenocarcinoma AJCC v7Stage II Prostate Adenocarcinoma AJCC v7Stage III Prostate Adenocarcinoma AJCC v7
NRG Oncology 612
Early research (Phase 1)Study completedNCT02603965
What this trial is testing

Copper Cu 64 TP3805 PET in Detecting Cancer in Patients With Prostate Cancer Undergoing Surgery

Who this might be right for
Prostate AdenocarcinomaStage IIB Prostate CancerStage III Prostate Cancer+1 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 25
Not applicableStudy completedNCT01411319
What this trial is testing

MRI-Guided Lattice Extreme Ablative Dose Radiotherapy For Prostate Cancer

Who this might be right for
Prostate CancerProstate Adenocarcinoma
University of Miami 25
Early research (Phase 1)Study completedNCT00502164
What this trial is testing

Study to Assess Safety and Tolerability of AZD2171 After Multiple Doses in Patients With Advanced Prostate Cancer

Who this might be right for
Advanced Prostate Adenocarcinoma
AstraZeneca 40
Early research (Phase 1)Ended earlyNCT00788307
What this trial is testing

Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to External-Beam Radiation Therapy

Who this might be right for
Prostate Cancer
Mayo Clinic 8
Testing effectiveness (Phase 2)Study completedNCT00331344
What this trial is testing

Treating Patients With Metastatic Prostate Cancer Not Responding to Hormone and Chemotherapy

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate CancerStage IV Prostate Cancer
National Cancer Institute (NCI) 100
Early research (Phase 1)Study completedNCT00002480
What this trial is testing

Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00225420
What this trial is testing

Docetaxel, Androgen Ablation, and External-Beam Radiation Therapy in Patients With High-Risk Localized Prostate Cancer

Who this might be right for
Prostate Cancer
UNC Lineberger Comprehensive Cancer Center 23
Testing effectiveness (Phase 2)Study completedNCT00020735
What this trial is testing

Toremifene Followed by Radical Prostatectomy in Treating Patients With Stage I or Stage II Prostate Cancer

Who this might be right for
Prostate Cancer
Joel Nelson, MD 45
Testing effectiveness (Phase 2)Study completedNCT00017563
What this trial is testing

Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancer

Who this might be right for
Prostate Cancer
OHSU Knight Cancer Institute 57
Very early researchLooking for participantsNCT05852041
What this trial is testing

RhPSMA-73 PET-MRI Imaging for the Detection of Prostate Cancer Among Men Who Are Otherwise Candidates for Active Surveillance

Who this might be right for
Prostate AdenocarcinomaStage I Prostate Cancer AJCC v8Stage IIA Prostate Cancer AJCC v8+1 more
Northwestern University 40
Not applicableStudy completedNCT02600156
What this trial is testing

Focal Laser Ablation of Low to Intermediate Prostate Cancer Tumors

Who this might be right for
Prostate CancerProstate AdenocarcinomaStage I Prostate Cancer AJCC v8+2 more
Mayo Clinic 7
Early research (Phase 1)Study completedNCT00020579
What this trial is testing

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

Who this might be right for
Cancer
National Institutes of Health Clinical Center (CC) 75
Not applicableStudy completedNCT02254746
What this trial is testing

A Phase I-II Dose Escalation Study of Stereotactic Body Radiation Therapy in Patients With Localized Prostate Cancer

Who this might be right for
Prostate Adenocarcinoma
Centre Hospitalier Universitaire Vaudois 27
Testing effectiveness (Phase 2)Study completedNCT01787331
What this trial is testing

Itraconazole in Treating Patients With Biochemically Relapsed Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaRecurrent Prostate CarcinomaStage I Prostate Adenocarcinoma AJCC v7+2 more
University of California, San Francisco 21
Load More Results